A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

New England Journal of Medicine - Tập 366 Số 9 - Trang 799-807 - 2012
Srđan Verstovšek1, Ruben A. Mesa2, Jason Gotlib3, Richard S. Levy4, Vikas Gupta5, John F. DiPersio6, John Catalano7, Michael W. Deininger8,9, Carole B. Miller10, Richard T. Silver11, Moshe Talpaz12, Elliott F. Winton13, John Collins Harvey, Murat O. Arcasoy14, Elizabeth O. Hexner15, Roger M. Lyons16, Ronald Paquette17, Azra Raza18, Kris Vaddi4, Susan Erickson‐Viitanen4, Iphigenia L. Koumenis4, William Sun4, Victor Sandor4, Hagop M. Kantarjian1
1University of Texas M.D. Anderson Cancer Center, Houston.
2Mayo Clinic, Scottsdale, AZ
3Stanford Cancer Institute, Stanford, CA
4Incyte, Wilmington, DE
5Princess Margaret Hospital, University of Toronto, Toronto.
6Washington University School of Medicine, St Louis
7Frankston Hospital and Monash University, Frankston, VIC, Australia
8Huntsman Cancer Institute, University of Utah, Salt Lake City
9Oregon Health and Science University, Portland
10Saint Agnes Cancer Institute, Baltimore
11Weill Cornell Medical Center
12University of Michigan, Ann Arbor
13Emory University School of Medicine, Atlanta
14Duke University Health System, Durham, NC
15Abramson Cancer Center at the University of Pennsylvania, Philadelphia
16Cancer Care Centers of South Texas and US Oncology, San Antonio
17UCLA Division of Hematology and Oncology, Los Angeles
18Columbia Presbyterian Medical Center

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1200/JCO.2010.32.9490

10.1182/blood-2008-07-170449

10.1146/annurev.med.60.041707.160528

10.1007/s12185-010-0530-z

10.1016/j.semcdb.2008.07.002

10.1182/blood-2009-04-214957

10.1056/NEJMoa1002028

10.1038/sj.leu.2404955

10.1097/00000421-198212000-00014

10.1002/cncr.26129

10.1182/blood-2009-03-208850

10.1182/blood-2006-03-009746

10.1016/j.ejrad.2009.08.013

10.1007/s003300000551

10.1007/s003300050145

Harrison C, 2012, N Engl J Med, 366, 787, 10.1056/NEJMoa1110556